AMRN
Price
$0.46
Change
-$0.01 (-2.13%)
Updated
Dec 12, 04:59 PM (EDT)
76 days until earnings call
HRTX
Price
$1.61
Change
-$0.07 (-4.14%)
Updated
Dec 12, 04:59 PM (EDT)
70 days until earnings call
Ad is loading...

AMRN vs HRTX

Header iconAMRN vs HRTX Comparison
Open Charts AMRN vs HRTXBanner chart's image
Amarin
Price$0.46
Change-$0.01 (-2.13%)
Volume$6.54K
CapitalizationN/A
Heron Therapeutics
Price$1.61
Change-$0.07 (-4.14%)
Volume$9.1K
CapitalizationN/A
AMRN vs HRTX Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. HRTX commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Hold and HRTX is a Buy.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (AMRN: $0.47 vs. HRTX: $1.69)
Brand notoriety: AMRN: Notable vs. HRTX: Not notable
AMRN represents the Pharmaceuticals: Major, while HRTX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 163% vs. HRTX: 72%
Market capitalization -- AMRN: $357.53M vs. HRTX: $243.35M
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. HRTX’s [@Biotechnology] market capitalization is $243.35M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $494.61B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileHRTX’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • HRTX’s FA Score: 0 green, 5 red.
According to our system of comparison, HRTX is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while HRTX’s TA Score has 5 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 6 bearish.
  • HRTX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, HRTX is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а -5.90% price change this week, while HRTX (@Biotechnology) price change was +3.05% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.04%. For the same industry, the average monthly price growth was -5.10%, and the average quarterly price growth was -0.77%.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.99%. For the same industry, the average monthly price growth was -6.13%, and the average quarterly price growth was +8.13%.

Reported Earning Dates

AMRN is expected to report earnings on Feb 26, 2025.

HRTX is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-1.04% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-0.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRN($358M) has a higher market cap than HRTX($262M). HRTX YTD gains are higher at: -0.588 vs. AMRN (-45.908). HRTX has higher annual earnings (EBITDA): -19.37M vs. AMRN (-50.7M). AMRN has more cash in the bank: 321M vs. HRTX (70.9M). AMRN has less debt than HRTX: AMRN (8.74M) vs HRTX (178M). AMRN has higher revenues than HRTX: AMRN (307M) vs HRTX (138M).
AMRNHRTXAMRN / HRTX
Capitalization358M262M137%
EBITDA-50.7M-19.37M262%
Gain YTD-45.908-0.5887,804%
P/E Ratio67.11N/A-
Revenue307M138M222%
Total Cash321M70.9M453%
Total Debt8.74M178M5%
FUNDAMENTALS RATINGS
AMRN vs HRTX: Fundamental Ratings
AMRN
HRTX
OUTLOOK RATING
1..100
5526
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
8962
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HRTX's Valuation (69) in the Biotechnology industry is in the same range as AMRN (85) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

HRTX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as HRTX (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to HRTX’s over the last 12 months.

HRTX's Price Growth Rating (62) in the Biotechnology industry is in the same range as AMRN (89) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

HRTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that HRTX’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNHRTX
RSI
ODDS (%)
Bullish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 11 days ago
71%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
89%
Bearish Trend 22 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IGEAX82.281.20
+1.48%
VY® T. Rowe Price Growth Equity A
OEGAX31.090.42
+1.37%
Invesco Discovery Mid Cap Growth A
OTGAX7.990.06
+0.76%
OTG Latin America A Shares
CBECX13.620.02
+0.15%
Allspring Large Cap Value CL C
ASRFX8.22-0.01
-0.12%
Invesco Global Real Estate Income R6

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
-6.59%
KZR - AMRN
56%
Loosely correlated
-0.86%
CNTB - AMRN
55%
Loosely correlated
+7.89%
HRTX - AMRN
44%
Loosely correlated
-3.43%
MGNX - AMRN
44%
Loosely correlated
+2.10%
ALXO - AMRN
43%
Loosely correlated
-4.43%
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-3.43%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
-6.59%
ABOS - HRTX
41%
Loosely correlated
+0.46%
ARDX - HRTX
40%
Loosely correlated
+0.95%
SNDX - HRTX
40%
Loosely correlated
-4.75%
More